RACHEL LAWRENCE: Open Payments
NPI 1699339606 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 9 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $435 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $253 |
| Novo Nordisk Inc | 2 | $145 |
| Insulet Corporation | 3 | $137 |
| Lilly USA, LLC | 1 | $119 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
Products named: TEPEZZA, Ozempic, Omnipod, ZEPBOUND, EVENITY, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across TX — which companies pay providers there.
